Magali Le Garff-Tavernier

8PUBLICATIONS
43CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGenetic immunologyStructural properties of condensed matter
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 04, 2026
High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1.

|Mar 27, 2025
Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Hugo Hernández-Tost, Nicolas Weiss, Sylvain Choquet

|Feb 04, 2025
ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study.

Louis Pérol, Adrien Grenier, Carole Soussain

|Aug 08, 2024
Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic Significance.

Oumaima Aboubakr, Caroline Houillier, Agusti Alentorn

|Apr 07, 2023
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.

Anne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier

|Mar 16, 2022
Prevalence of IGLV3-21R110 among familial CLL: a retrospective study of 45 cases.

Marine Armand, Patricia Verrier, Floriane Theves

Pageof 2

Frequent Collaborators

3 joint publications

Sylvain Choquet

3 joint publications

Caroline Houillier

2 joint publications

Khê Hoang-Xuan

2 joint publications

Delphine Leclercq